Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
about
Glial cell line-derived neurotrophic factor reverses ethanol-mediated increases in tyrosine hydroxylase immunoreactivity via altering the activity of heat shock protein 90GFRalpha3 is an orphan member of the GDNF/neurturin/persephin receptor familyGFRalpha-2 and GFRalpha-3 are two new receptors for ligands of the GDNF familyEffects of cerebral ischemia in mice deficient in Persephin.Imaging of peripheral benzodiazepine receptor expression as biomarkers of detrimental versus beneficial glial responses in mouse models of Alzheimer's and other CNS pathologiesGFRalpha1 is an essential receptor component for GDNF in the developing nervous system and kidneyNeural stem cells express melatonin receptors and neurotrophic factors: colocalization of the MT1 receptor with neuronal and glial markersMicroglia-Mediated Neuroinflammation and Neurotrophic Factor-Induced Protection in the MPTP Mouse Model of Parkinson's Disease-Lessons from Transgenic MiceGlial-derived neurotrophic factor gene transfer for Parkinson's disease: anterograde distribution of AAV2 vectors in the primate brainTreating Parkinson's disease in the 21st century: can stem cell transplantation compete?Noninvasive, Targeted, and Non-Viral Ultrasound-Mediated GDNF-Plasmid Delivery for Treatment of Parkinson's Disease.Comparative Analysis of the Effects of Neurotrophic Factors CDNF and GDNF in a Nonhuman Primate Model of Parkinson's DiseaseTowards Clinical Application of Neurotrophic Factors to the Auditory Nerve; Assessment of Safety and Efficacy by a Systematic Review of Neurotrophic Treatments in Humans.GDNF-based therapies, GDNF-producing interneurons, and trophic support of the dopaminergic nigrostriatal pathway. Implications for Parkinson's diseaseEnovin, a member of the glial cell-line-derived neurotrophic factor (GDNF) family with growth promoting activity on neuronal cells. Existence and tissue-specific expression of different splice variantsCalcitriol protects against the dopamine- and serotonin-depleting effects of neurotoxic doses of methamphetamineMethamphetamine preconditioning alters midbrain transcriptional responses to methamphetamine-induced injury in the rat striatumIdentification and characterization of GFRalpha-3, a novel Co-receptor belonging to the glial cell line-derived neurotrophic receptor familyGDNF-transfected macrophages produce potent neuroprotective effects in Parkinson's disease mouse modelThe candidate neuroprotective agent artemin induces autonomic neural dysplasia without preventing peripheral nerve dysfunctionA synopsis on the role of tyrosine hydroxylase in Parkinson's diseaseAutologous transplantation of GDNF-expressing mesenchymal stem cells protects against MPTP-induced damage in cynomolgus monkeysProtection from MPTP-induced neurotoxicity in differentiating mouse N2a neuroblastoma cells.GDNF reverses priming for dyskinesia in MPTP-treated, L-DOPA-primed common marmosets.BDNF-dependent stimulation of dopamine D5 receptor expression in developing striatal astrocytes involves PI3-kinase signaling.GDNF selectively induces microglial activation and neuronal survival in CA1/CA3 hippocampal regions exposed to NMDA insult through Ret/ERK signalling.Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisLong distance directional growth of dopaminergic axons along pathways of netrin-1 and GDNF.Etiology of Parkinson's disease.Neuroprotective effects of brain-derived neurotrophic factor in rodent and primate models of Alzheimer's diseaseStroke triggers nigrostriatal plasticity and increases alcohol consumption in rats.Glial cell line-derived neurotrophic factor gene therapy ameliorates chronic hyperprolactinemia in senile rats.Safety evaluation of AAV2-GDNF gene transfer into the dopaminergic nigrostriatal pathway in aged and parkinsonian rhesus monkeys.5-HT2A receptor antagonists improve motor impairments in the MPTP mouse model of Parkinson's disease.Glial cell line-derived neurotrophic factor but not transforming growth factor beta 3 prevents delayed degeneration of nigral dopaminergic neurons following striatal 6-hydroxydopamine lesion.Retrograde axonal transport of glial cell line-derived neurotrophic factor in the adult nigrostriatal system suggests a trophic role in the adult.Therapeutic potential of neurotrophic factors and neural stem cells against ischemic brain injury.Targeting eNOS and beyond: emerging heterogeneity of the role of endothelial Rho proteins in stroke protectionGDNF - a stranger in the TGF-beta superfamily?Neurturin protects against 6-hydroxydopamine-induced reductions in evoked dopamine overflow in rat striatum.
P2860
Q24311534-5ADAD5B2-3491-4332-97D6-A6660927D36BQ24313994-9E256E42-168A-495A-8836-B7C3C1377FFBQ24315709-C2AF86B5-2B78-4988-BEED-4EA45A9DE87EQ24534911-F0A68A10-49D5-475D-B316-C6B043298AFAQ24642726-23DD340E-E66B-477D-8255-9EA07EF69AAAQ24649094-DA575068-A07F-4A82-A504-BFA99AB1DE7BQ24795063-7B14F588-3661-48F7-A461-F671E4C8480CQ26773064-EC69257D-697F-4340-9010-4A32B8D1B740Q27002651-151D9895-D393-45A7-9AAB-443A25B82550Q27024152-71ADAA59-3CD4-47D6-B889-6797A2AC3D95Q27301281-9AB1A2B9-805A-45F0-9335-7BF406978CCBQ27320553-0F4A4ECF-15EC-498E-845D-C9D3613FFAD9Q28067169-5555F733-945C-4402-A4EA-1A7F07E24827Q28088320-44BB695B-DF6D-4BC7-B91E-AE684293F065Q28139368-97C7E49C-C646-4F28-8A25-497E8145F808Q28274130-D15B31E6-21C0-4EE8-B58F-97FE3E90073CQ28471860-17907F7C-1A19-4E1C-8E58-DC4BF62A21DBQ28513903-2E8A810A-DCC8-45CD-AAD3-2D8DF24FE3A6Q28543023-8EB5E12B-12B2-45EE-AA00-30B45542122AQ28591458-4E384879-DD44-4944-B79F-65678BC86D8BQ28830946-BA34E63E-7607-4387-A537-8AA25D7EBAEDQ30581632-AD91BEBD-F554-4EAE-B3FA-1BDE07DF408AQ31832127-DEBBB708-8B5D-4CC6-86E6-F5F83265A063Q31900813-8A421C52-48B3-4C14-8EA6-C8BC5C38CD35Q33200407-384D26C6-0FA5-4597-A223-198C6B2DAA97Q33489521-166966C9-8E4D-4ECE-BBAD-396FFFA0AEB0Q33589580-A1910FDE-E835-49C0-B772-9A843A7C5CE0Q33684997-73E99974-5358-440F-94D2-D08C72F8F80FQ33714108-44260801-EB95-48A1-A8DD-39D4DC90AEDBQ33726762-29C24F89-EDCA-4A06-9B13-1E92AD3292B6Q33746834-DCD6C4D0-2CE8-4B88-BD33-6F3F066907F1Q33787660-592A86DC-F463-4F00-842E-A645FCF43277Q33819946-19220220-FC74-419D-8969-0D80A2C6F69AQ33886545-7180CA06-5596-4C7F-894F-1CEC0ACD3EA2Q33939425-61C80630-2555-4D24-BFF8-F6EC30B6F878Q33964044-73068A48-98CE-488F-85B4-B6CB8E3B8B62Q34067458-A2ED4E1D-AEEC-4209-A18A-9923D93A3147Q34088803-7EBE8559-B78F-4299-BD9F-7111F4257E59Q34098852-4D594412-C96D-4FAF-9832-A9513128561DQ34108184-CD79DA55-274A-4035-A55C-8D9EA3B205EA
P2860
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
description
1995 nî lūn-bûn
@nan
1995 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
1995 թվականի հունվարին հրատարակված գիտական հոդված
@hy
1995年の論文
@ja
1995年論文
@yue
1995年論文
@zh-hant
1995年論文
@zh-hk
1995年論文
@zh-mo
1995年論文
@zh-tw
1995年论文
@wuu
name
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@ast
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@en
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@nl
type
label
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@ast
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@en
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@nl
prefLabel
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@ast
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@en
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@nl
P2093
P3181
P356
P1433
P1476
Protection and repair of the nigrostriatal dopaminergic system by GDNF in vivo
@en
P2093
P2888
P3181
P356
10.1038/373335A0
P407
P577
1995-01-26T00:00:00Z
P6179
1003743762